Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Towards new strategies to manage livestock reproduction using kisspeptin analogs.

Beltramo M, Decourt C.

Theriogenology. 2018 May;112:2-10. doi: 10.1016/j.theriogenology.2017.08.026. Epub 2017 Sep 12.

PMID:
28916209
2.

Cross-Linking Furan-Modified Kisspeptin-10 to the KISS Receptor.

Vannecke W, Ampe C, Van Troys M, Beltramo M, Madder A.

ACS Chem Biol. 2017 Aug 18;12(8):2191-2200. doi: 10.1021/acschembio.7b00396. Epub 2017 Jul 17.

PMID:
28714670
3.

RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.

Elhabazi K, Humbert JP, Bertin I, Quillet R, Utard V, Schneider S, Schmitt M, Bourguignon JJ, Laboureyras E, Ben Boujema M, Simonnet G, Ancel C, Simonneaux V, Beltramo M, Bucher B, Sorg T, Meziane H, Schneider E, Petit-Demoulière B, Ilien B, Bihel F, Simonin F.

Neuropharmacology. 2017 May 15;118:188-198. doi: 10.1016/j.neuropharm.2017.03.012. Epub 2017 Mar 10.

PMID:
28288815
4.

Intestinal Obstruction Caused by Ileocolic and Colocolic Intussusception in an Adult Patient with Cecal Lipoma.

Casiraghi T, Masetto A, Beltramo M, Girlando M, Di Bella C.

Case Rep Surg. 2016;2016:3519606. doi: 10.1155/2016/3519606. Epub 2016 Dec 4.

5.

A synthetic kisspeptin analog that triggers ovulation and advances puberty.

Decourt C, Robert V, Anger K, Galibert M, Madinier JB, Liu X, Dardente H, Lomet D, Delmas AF, Caraty A, Herbison AE, Anderson GM, Aucagne V, Beltramo M.

Sci Rep. 2016 Jun 1;6:26908. doi: 10.1038/srep26908.

6.

Seasonal breeding in mammals: From basic science to applications and back.

Dardente H, Lomet D, Robert V, Decourt C, Beltramo M, Pellicer-Rubio MT.

Theriogenology. 2016 Jul 1;86(1):324-32. doi: 10.1016/j.theriogenology.2016.04.045. Epub 2016 Apr 21. Review.

PMID:
27173960
7.

No Evidence That RFamide-Related Peptide 3 Directly Modulates LH Secretion in the Ewe.

Decourt C, Anger K, Robert V, Lomet D, Bartzen-Sprauer J, Caraty A, Dufourny L, Anderson G, Beltramo M.

Endocrinology. 2016 Apr;157(4):1566-75. doi: 10.1210/en.2015-1854. Epub 2016 Feb 10.

PMID:
26862995
8.

Anxiogenic and Stressor Effects of the Hypothalamic Neuropeptide RFRP-3 Are Overcome by the NPFFR Antagonist GJ14.

Kim JS, Brownjohn PW, Dyer BS, Beltramo M, Walker CS, Hay DL, Painter GF, Tyndall JD, Anderson GM.

Endocrinology. 2015 Nov;156(11):4152-62. doi: 10.1210/en.2015-1532. Epub 2015 Aug 10.

PMID:
26259035
9.

Rational design of triazololipopeptides analogs of kisspeptin inducing a long-lasting increase of gonadotropins.

Beltramo M, Robert V, Galibert M, Madinier JB, Marceau P, Dardente H, Decourt C, De Roux N, Lomet D, Delmas AF, Caraty A, Aucagne V.

J Med Chem. 2015 Apr 23;58(8):3459-70. doi: 10.1021/jm5019675. Epub 2015 Apr 13.

PMID:
25811530
10.

Acute injection and chronic perfusion of kisspeptin elicit gonadotropins release but fail to trigger ovulation in the mare.

Decourt C, Caraty A, Briant C, Guillaume D, Lomet D, Chesneau D, Lardic L, Duchamp G, Reigner F, Monget P, Dufourny L, Beltramo M, Dardente H.

Biol Reprod. 2014 Feb 20;90(2):36. doi: 10.1095/biolreprod.113.114157. Print 2014 Feb.

PMID:
24429215
11.

Cellular mechanisms and integrative timing of neuroendocrine control of GnRH secretion by kisspeptin.

Beltramo M, Dardente H, Cayla X, Caraty A.

Mol Cell Endocrinol. 2014 Jan 25;382(1):387-399. doi: 10.1016/j.mce.2013.10.015. Epub 2013 Oct 18. Review.

PMID:
24145132
12.

Immunohistochemical evidence for the presence of various kisspeptin isoforms in the mammalian brain.

Franceschini I, Yeo SH, Beltramo M, Desroziers E, Okamura H, Herbison AE, Caraty A.

J Neuroendocrinol. 2013 Sep;25(9):839-51. doi: 10.1111/jne.12069.

PMID:
23822722
13.
14.

Kisspeptins and the reproductive axis: potential applications to manage reproduction in farm animals.

Caraty A, Decourt C, Briant C, Beltramo M.

Domest Anim Endocrinol. 2012 Aug;43(2):95-102. doi: 10.1016/j.domaniend.2012.03.002. Epub 2012 Apr 10. Review.

PMID:
22533939
15.

RF9 powerfully stimulates gonadotrophin secretion in the ewe: evidence for a seasonal threshold of sensitivity.

Caraty A, Blomenröhr M, Vogel GM, Lomet D, Briant C, Beltramo M.

J Neuroendocrinol. 2012 May;24(5):725-36. doi: 10.1111/j.1365-2826.2012.02283.x.

PMID:
22283564
16.

Structure-activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain.

Yang SW, Smotryski J, Matasi J, Ho G, Tulshian D, Greenlee WJ, Brusa R, Beltramo M, Cox K.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):182-5. doi: 10.1016/j.bmcl.2010.11.044. Epub 2010 Nov 11.

PMID:
21115245
17.

The somatostatin analogue octreotide inhibits capsaicin-mediated activation of nociceptive primary afferent fibres in spinal cord lamina II (substantia gelatinosa).

Bencivinni I, Ferrini F, Salio C, Beltramo M, Merighi A.

Eur J Pain. 2011 Jul;15(6):591-9. doi: 10.1016/j.ejpain.2010.11.001. Epub 2010 Nov 24.

18.

Detecting constitutive activity and protean agonism at cannabinoid-2 receptor.

Beltramo M, Brusa R, Mancini I, Scandroglio P.

Methods Enzymol. 2010;484:31-51. doi: 10.1016/B978-0-12-381298-8.00002-2.

PMID:
21036225
19.

Evaluation of cannabinoid receptor 2 and metabotropic glutamate receptor 1 functional responses using a cell impedance-based technology.

Scandroglio P, Brusa R, Lozza G, Mancini I, Petrò R, Reggiani A, Beltramo M.

J Biomol Screen. 2010 Dec;15(10):1238-47. doi: 10.1177/1087057110375615. Epub 2010 Sep 1.

PMID:
20811068
20.

Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.

Mancini I, Brusa R, Quadrato G, Foglia C, Scandroglio P, Silverman LS, Tulshian D, Reggiani A, Beltramo M.

Br J Pharmacol. 2009 Sep;158(1):382-91. doi: 10.1111/j.1476-5381.2009.00154.x. Epub 2009 Jun 22.

21.

[The cannabinoid system and pain: towards new drugs?].

Beltramo M.

J Soc Biol. 2009;203(1):99-106. doi: 10.1051/jbio:2009002. Epub 2009 Apr 10. Review. French.

PMID:
19358815
22.

Cannabinoid type 2 receptor as a target for chronic - pain.

Beltramo M.

Mini Rev Med Chem. 2009 Jan;9(1):11-25. Review.

PMID:
19149657
23.

Identification of single nucleotide polymorphisms of the human metabotropic glutamate receptor 1 gene and pharmacological characterization of a P993S variant.

Downey PM, Petrò R, Simon JS, Devlin D, Lozza G, Veltri A, Beltramo M, Bertorelli R, Reggiani A.

Biochem Pharmacol. 2009 Apr 1;77(7):1246-53. doi: 10.1016/j.bcp.2008.12.003. Epub 2008 Dec 25.

PMID:
19146831
24.

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms.

Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, Reggiani A.

Eur J Neurosci. 2006 Mar;23(6):1530-8.

PMID:
16553616
25.

Regulation of two rat mas-related genes in a model of neuropathic pain.

Gustafson EL, Maguire M, Campanella M, Tarozzo G, Jia Y, Dong XW, Laverty M, Murgolo N, Priestley T, Reggiani A, Monsma F, Beltramo M.

Brain Res Mol Brain Res. 2005 Dec 7;142(1):58-64. Epub 2005 Oct 24.

PMID:
16246453
26.

Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies.

Conti A, Ricchiuto P, Iannaccone S, Sferrazza B, Cattaneo A, Bachi A, Reggiani A, Beltramo M, Alessio M.

Proteomics. 2005 Nov;5(17):4558-67.

PMID:
16196102
27.

Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain.

Bertorelli R, Fredduzzi S, Tarozzo G, Campanella M, Grundy R, Beltramo M, Reggiani A.

Behav Brain Res. 2005 Feb 10;157(1):55-62.

PMID:
15617771
28.

Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers.

Conti A, Sanchez-Ruiz Y, Bachi A, Beretta L, Grandi E, Beltramo M, Alessio M.

J Neurotrauma. 2004 Jul;21(7):854-63.

PMID:
15307898
29.

Gene expression profiling of melanocortin system in neuropathic rats supports a role in nociception.

Beltramo M, Campanella M, Tarozzo G, Fredduzzi S, Corradini L, Forlani A, Bertorelli R, Reggiani A.

Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):111-8.

PMID:
14559360
30.

Fractalkine protein localization and gene expression in mouse brain.

Tarozzo G, Bortolazzi S, Crochemore C, Chen SC, Lira AS, Abrams JS, Beltramo M.

J Neurosci Res. 2003 Jul 1;73(1):81-8.

PMID:
12815711
31.

Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat.

Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M.

Eur J Neurosci. 2002 May;15(10):1663-8.

PMID:
12059974
32.

Cannabinoids and neuroprotection.

Grundy RI, Rabuffetti M, Beltramo M.

Mol Neurobiol. 2001 Aug-Dec;24(1-3):29-51. Review.

PMID:
11831553
33.

Relationships between CB1 cannabinoid receptors and pituitary endocrine cells in Xenopus laevis: an immunohistochemical study.

Cesa R, Guastalla A, Cottone E, Mackie K, Beltramo M, Franzoni MF.

Gen Comp Endocrinol. 2002 Jan;125(1):17-24.

PMID:
11825030
34.

Flow cytometric analysis of inflammatory cells in ischemic rat brain.

Campanella M, Sciorati C, Tarozzo G, Beltramo M.

Stroke. 2002 Feb;33(2):586-92.

35.

Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis.

Cesa R, Mackie K, Beltramo M, Franzoni MF.

Cell Tissue Res. 2001 Dec;306(3):391-8. Epub 2001 Sep 25.

PMID:
11735039
36.

Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.

Giuffrida A, Beltramo M, Piomelli D.

J Pharmacol Exp Ther. 2001 Jul;298(1):7-14. Review.

37.

[Acute respiratory failure due to lipoid pneumonia].

Soloaga ED, Beltramo MN, Veltri MA, Ubaldini JE, Chertcoff FJ.

Medicina (B Aires). 2000;60(5 Pt 1):602-4. Spanish.

PMID:
11188900
39.
40.

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.

Beltramo M, de Fonseca FR, Navarro M, Calignano A, Gorriti MA, Grammatikopoulos G, Sadile AG, Giuffrida A, Piomelli D.

J Neurosci. 2000 May 1;20(9):3401-7.

41.

Structural determinants for recognition and translocation by the anandamide transporter.

Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie XQ, Makriyannis A.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5802-7.

42.

Endogenous cannabinoid signaling.

Piomelli D, Beltramo M, Giuffrida A, Stella N.

Neurobiol Dis. 1998 Dec;5(6 Pt B):462-73. Review. No abstract available.

PMID:
9974178
43.

Anandamide transport inhibition by the vanilloid agonist olvanil.

Beltramo M, Piomelli D.

Eur J Pharmacol. 1999 Jan 1;364(1):75-8.

44.

Inhibition of intestinal motility by anandamide, an endogenous cannabinoid.

Calignano A, La Rana G, Makriyannis A, Lin SY, Beltramo M, Piomelli D.

Eur J Pharmacol. 1997 Dec 11;340(2-3):R7-8.

PMID:
9537804
45.

Immunolocalization of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, dopamine, and serotonin in the forebrain of Ambystoma mexicanum.

Beltramo M, Pairault C, Krieger M, Thibault J, Tillet Y, Clairambault P.

J Comp Neurol. 1998 Feb 9;391(2):227-47.

PMID:
9518271
46.

Potentiation of anandamide hypotension by the transport inhibitor, AM404.

Calignano A, La Rana G, Beltramo M, Makriyannis A, Piomelli D.

Eur J Pharmacol. 1997 Oct 15;337(1):R1-2.

47.

Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D.

Science. 1997 Aug 22;277(5329):1094-7.

48.

Long-lasting effect of catecholamine deficiency on differentiating vasopressin and oxytocin neurons in the rat supraoptic nucleus.

Beltramo M, Calas A, Chernigovskaya E, Thibault J, Ugrumov M.

Neuroscience. 1997 Jul;79(2):555-61.

PMID:
9200738
49.
50.

Endogenous lipids that activate cannabinoid receptors. Formation and inactivation.

Di Tomaso E, Cadas H, Gaillet S, Beltramo M, Desarnaud F, Venance L, Piomelli D.

Adv Exp Med Biol. 1997;407:335-40. Review. No abstract available.

PMID:
9321973

Supplemental Content

Loading ...
Support Center